Skip to content
Log in
Sponsored Artificial Intelligence: A Modern Approach, Global Edition Artificial Intelligence: A Modern Approach, Global Edition
Open access

Clinical Trial: Phase 3 Trial of Resmetirom Versus Placebo in Metabolic Dysfunction‐Associated Steatohepatitis—Reanalysis of Fibrosis Stage 2–3 Subset

Maria Mironova K. Padmanabhan David Schneider J. Schattenberg R. Loomba
Jul 2026 · Alimentary Pharmacology and Therapeutics · Vol 64, pp. 919 - 929 · 2 citations · 24 references
Medicine

Abstract

Resmetirom is an oral thyroid hormone receptor beta agonist clinically used to treat metabolic dysfunction‐associated steatohepatitis (MASH) among adults with stage F2 or F3 fibrosis.

DOI PubMed Semantic Scholar
Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.